Both in Pharmaceuticals
Pfizer vs ABBVIE
Over the past year PFE returned +23.8% and ABBV returned +35.2%; their daily moves had a correlation of 0.37.
PFE +23.8% ABBV +35.2%Growth of $1, one year, split-adjusted
| Metric | PFE | ABBV |
|---|---|---|
| Price | $30.52 | $294.89 |
| Market cap | $173.95B | $521.11B |
| Today | +1.90% | +1.41% |
| 1 month | +8.5% | +13.4% |
| 6 months | +15.9% | +42.7% |
| Year to date | +22.6% | +29.1% |
| 1 year | +25.6% | +31.0% |
| Revenue growth (YoY) | +2.6% | +10.2% |
| Gross margin | 72.8% | 74.7% |
| Net margin | −1.6% | 21.3% |
| P/E (TTM) | 40.2× | 82.8× |
| Price / sales | 2.7× | 8.1× |
| Net cash | -$51.49B | -$64.25B |
| Dividend yield | 5.64% | 2.35% |
| Volatility (60d) | 19.8% | 19.6% |
| Short % of float | 2.4% | 0.9% |
| Next earnings | Nov 3, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).